Gene · 994
Papers2,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| One-Pot Green Synthesis of Acridine Alkaloid Derivatives and Screening of in vitro Anti-cancer Activity Against Cdc25b and SHP1. | Curr Org Synth | 2021 | 33371849 | PubTator, text mining | PubMed |
| lncRNA LIFR‑AS1 inhibits gastric carcinoma cell proliferation, migration and invasion by sponging miR‑4698. | Mol Med Rep | 2021 | 33355363 | PubTator, text mining | PubMed |
| Elevated CDK5R1 predicts worse prognosis in hepatocellular carcinoma based on TCGA data. | Biosci Rep | 2021 | 33346796 | PubTator, text mining | PubMed |
| 5-Aryl-furan derivatives bearing a phenylalanine- or isoleucine-derived rhodanine moiety as potential PTP1B inhibitors. | Bioorg Chem | 2021 | 33268007 | PubTator, text mining | PubMed |
| Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer. | Cell Mol Immunol | 2021 | 32939032 | PubTator, text mining | PubMed |
| Effective Pharmacophore for CDC25 Phosphatases Enzyme Inhibitors: Newly Synthesized Bromothiazolopyrimidine Derivatives. | Mini Rev Med Chem | 2021 | 32560601 | PubTator, text mining | PubMed |
| Dihydronaphthofurans: synthetic strategies and applications. | RSC Adv | 2020 | 35497409 | PubTator, text mining | PubMed |
Retracted Article: Overexpression of circ_0034642 contributes to hypoxia-induced glycolysis, cell proliferation, migration and invasion in gliomas by facilitating TAGLN2 expression via sponging miR-625-5p. | RSC Adv | 2020 | 35494452 | PubTator, text mining | PubMed |
| Menadione reduces CDC25B expression and promotes tumor shrinkage in gastric cancer. | Ther Adv Gastroenterol | 2020 | 35392297 | PubTator, text mining | PubMed |
| Construction of a potential microRNA, transcription factor and mRNA regulatory network in hepatocellular carcinoma. | Transl Cancer Res | 2020 | 35117917 | PubTator, text mining | PubMed |
| Comprehensive analysis of competitive endogenous RNA network in colorectal cancer. | Transl Cancer Res | 2020 | 35117797 | PubTator, text mining | PubMed |
| A novel gene expression test method of minimizing breast cancer risk in reduced cost and time by improving SVM-RFE gene selection method combined with LASSO. | J Integr Bioinform | 2020 | 34171941 | PubTator, text mining | PubMed |
| Identification of Molecular Signatures in Mild Intrinsic Atopic Dermatitis by Bioinformatics Analysis. | Ann Dermatol | 2020 | 33911724 | PubTator, text mining | PubMed |
| Metastatic Spread in Prostate Cancer Patients Influencing Radiotherapy Response. | Front Oncol | 2020 | 33747899 | PubTator, text mining | PubMed |
| FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis. | Front Oncol | 2020 | 33680951 | PubTator, text mining | PubMed |
| Aberrant Expression of Long Non-coding RNAs in Exosomes in Follicle Fluid From PCOS Patients. | Front Genet | 2020 | 33679867 | PubTator, text mining | PubMed |
| The Paradoxical Behavior of microRNA-211 in Melanomas and Other Human Cancers. | Front Oncol | 2020 | 33628737 | PubTator, text mining | PubMed |
| Timosaponin AIII Induces G2/M Arrest and Apoptosis in Breast Cancer by Activating the ATM/Chk2 and p38 MAPK Signaling Pathways. | Front Pharmacol | 2020 | 33628174 | PubTator, text mining | PubMed |
Tissue Treg Secretomes and Transcription Factors Shared With Stem Cells Contribute to a Treg Niche to Maintain Treg-Ness With 80% Innate Immune Pathways, and Functions of Immunosuppression and Tissue Repair. | Front Immunol | 2020 | 33613572 | PubTator, text mining | PubMed |
| Sulforaphane in broccoli: The green chemoprevention!! Role in cancer prevention and therapy. | J Oral Maxillofac Pathol | 2020 | 33456268 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/994/papers?page=27